As of February 2026 CRISPR Therapeutics has a market cap of A$7.05 Billion. This makes CRISPR Therapeutics the world's 3157th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 3rd, 2026 the market cap of CRISPR Therapeutics was reported to be: